Evidence map›Paper›PMID 30131870›Full record

ArticleNPJ systems biology and applications2018

Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease.

Elaina M Maldonado, Ciarán P Fisher, Dawn J Mazzatti, Amy L Barber, Marcus J Tindall, Nicholas J Plant, Andrzej M Kierzek, J Bernadette Moore

Open access · goldAbstract read
In one paragraph

Article in NPJ systems biology and applications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Frontiers in nutrition · 2022
    Article
  10. Dietary carbohydrates and fats in nonalcoholic fatty liver disease.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Computational Modeling of Fructose Metabolism and Development in NAFLD.Frontiers in bioengineering and biotechnology · 2020
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Elaina M Maldonado *1School of Biosciences and Medicine, University of Surrey, Guildford, Surrey, GU2 7XH UK.
Ciarán P Fisher *Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ UK.
Dawn J Mazzatti3Proctor & Gamble, Cincinnati, OH 45224 USA.
Amy L Barber1School of Biosciences and Medicine, University of Surrey, Guildford, Surrey, GU2 7XH UK.
Marcus J Tindall4Department of Mathematics and Statistics, University of Reading, Berkshire, RG6 6AX UK.
Nicholas J Plant1School of Biosciences and Medicine, University of Surrey, Guildford, Surrey, GU2 7XH UK.
Andrzej M Kierzek1School of Biosciences and Medicine, University of Surrey, Guildford, Surrey, GU2 7XH UK.
J Bernadette Moore1School of Biosciences and Medicine, University of Surrey, Guildford, Surrey, GU2 7XH UK.ORCID 0000-0003-4750-1550
University of Surrey · GBUniversity of Leeds · GBProcter & Gamble (United States) · USSimcyp (United Kingdom) · GBUniversity of Reading · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a serious public health issue associated with high fat, high sugar diets. However, the molecular mechanisms mediating NAFLD pathogenesis are only partially understood. Here we adopt an iterative multi-scale, systems biology approach coupled to in vitro experimentation to investigate the roles of sugar and fat metabolism in NAFLD pathogenesis. The use of fructose as a sweetening agent is controversial; to explore this, we developed a predictive model of human monosaccharide transport, signalling and metabolism. The resulting quantitative model comprising a kinetic model describing monosaccharide transport and insulin signalling integrated with a hepatocyte-specific genome-scale metabolic network (GSMN). Differential kinetics for the utilisation of glucose and fructose were predicted, but the resultant triacylglycerol production was predicted to be similar for monosaccharides; these predictions were verified by in vitro data. The role of physiological adaptation to lipid overload was explored through the comprehensive reconstruction of the peroxisome proliferator activated receptor alpha (PPARα) regulome integrated with a hepatocyte-specific GSMN. The resulting qualitative model reproduced metabolic responses to increased fatty acid levels and mimicked lipid loading in vitro. The model predicted that activation of PPARα by lipids produces a biphasic response, which initially exacerbates steatosis. Our data support the evidence that it is the quantity of sugar rather than the type that is critical in driving the steatotic response. Furthermore, we predict PPARα-mediated adaptations to hepatic lipid overload, shedding light on potential challenges for the use of PPARα agonists to treat NAFLD.

Identifiers

PMID30131870
PMCPMC6102210
OpenAlexW2887433896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.